Cargando…
Protein kinase inhibitors for acute leukemia
Conventional treatments for acute leukemia include chemotherapy, radiation therapy, and intensive combined treatments (including bone marrow transplant or stem cell transplants). Novel treatment approaches are in active development. Recently, protein kinase inhibitors are on clinical trials and offe...
Autores principales: | Ling, Yuan, Xie, Qing, Zhang, Zikang, Zhang, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809833/ https://www.ncbi.nlm.nih.gov/pubmed/29456860 http://dx.doi.org/10.1186/s40364-018-0123-1 |
Ejemplares similares
-
Protein Kinase Inhibitors as Therapeutic Drugs in AML: Advances and Challenges
por: Ling, Yuan, et al.
Publicado: (2017) -
Combination Therapies with Kinase Inhibitors for Acute Myeloid Leukemia Treatment
por: Takahashi, Shinichiro
Publicado: (2023) -
JAK kinase inhibitors for the treatment of acute lymphoblastic leukemia
por: Degryse, Sandrine, et al.
Publicado: (2015) -
Overcoming Resistance to Kinase Inhibitors: The Paradigm of Chronic Myeloid Leukemia
por: De Santis, Sara, et al.
Publicado: (2022) -
Growth of tyrosine kinase inhibitor-resistant Philadelphia-positive acute lymphoblastic leukemia: Role of bone marrow stromal cells
por: Zhang, Cheng, et al.
Publicado: (2017)